Cited by 3,481Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Open access

Gibb, W R, Lees, A J·1988·Journal of Neurology, Neurosurgery & Psychiatry

DOI 10.1136/jnnp.51.6.745PMC PMC1033142

Open this paper in CoChat — free account Open PDF

Abstract

The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/jnnp.51.6.745

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 535
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & Langston, J. W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?
Kosaka, K., Yoshimura, M., Ikeda, K., & Budka, H. (1984) · PubMed · Cited by 401
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 351
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 347
PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE
Duffy, P. E., & Tennyson, V. M. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196507000-00003 · Cited by 345
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
Gibb, W. R. G., & Lees, A. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01147.x · Cited by 325
Self-citation
Esophageal Lewy bodies associated with ganglion cell loss in achalasia
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90079-9 · Cited by 305
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · PubMed · Cited by 295

Show all 39 references

Research works printed but not linked: 7

Gibb WRG. The Lewy body and Parkinson's disease. In: Clifford Rose F, ed. Parkinson's Disease: Clinical and Experimental Advances. London: John Libbey and Co, 1987:3-11.
Oppenheimer D. Neuropathology of progressive autonomic failure. In: Bannister R, ed. Autonomic failure. Oxford University Press, London, 1983:267-83.
Sigwald J, Lapresle J, Raverdy P, Recondo NJ. Atrophie cerebelleuse familiale avec association de lesions nigeriennes et spinales. Presse Med 1964;72:557-62.
Vogt C, Vogt 0. Erkrankungen der GroBhirnrinde im Lichte der Topistik, Pathoklise und Pathoarchitektonik. J Psychol Neurol 1922;28:1-171.
Hamada S, Ishii T. The Lewy body in the brain of the aged. Adv Neurol Sci 1963;7:184-6.
Hirai S. Ageing of the substantia nigra. Adv Neurol Sci 1968;12:845-9.
Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476.

Sorted by citations

Items 601–700 of 1,022

Autotransplantation of Human Carotid Body Cell Aggregates for Treatment of Parkinson’s Disease
Arjona, V., Mínguez‐Castellanos, A., Montoro, R. J., Ortega, A., Sevilla, F. E., Toledo‐Aral, J. J., Pardal, R., Méndez‐Ferrer, S., Martín, J. M., Pérez-Garcı́a, M., et al. (2003) · Neurosurgery · doi:10.1227/01.neu.0000073315.88827.72 · Cited by 100
Decision making, impulsivity, and addictions: Do Parkinson's disease patients jump to conclusions?
Djamshidian, A., O’Sullivan, S. S., Sanotsky, Y., Sharman, S., Matviyenko, Y., Foltynie, T., Michalczuk, R., Avilés-Olmos, I., Fedoryshyn, L., Doherty, K. A., et al. (2012) · Movement Disorders · doi:10.1002/mds.25105 · Cited by 102
Self-citation
Neuropathology of Huntington's Disease
Vonsattel, J. P., Keller, C. E., & Amaya, M. D. P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01256-0 · Cited by 101
Parkinson's Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
Jenner, P. G., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben‐Shlomo, Y., Bolam, J. P., Burn, D. J., Hindle, J. V., Brooks, D. J., et al. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130175 · Cited by 103
TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies
Arnold, S. J., Dugger, B. N., & Beach, T. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1110-0 · Cited by 100
Impairment of the supervisory attentional system in early untreated patients with Parkinson’s disease
Dujardin, K., Degreef, J., Rogelet, P., Defebvre, L., & Destée, A. (1999) · Journal of Neurology · doi:10.1007/s004150050455 · Cited by 115
Estrogens and Parkinson Disease: Neuroprotective, Symptomatic, Neither, or Both?
Saunders-Pullman, R. J. (2003) · Endocrine · doi:10.1385/endo:21:1:81 · Cited by 100
Neuronal pathology in Parkinson?s disease
Schulz, J. B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1081-0 · Cited by 100
Retracted
Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?
Unger, M. M., Möller, J. C., Mankel, K., Eggert, K. M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P. H., Mayer, G., Tebbe, J. J., et al. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5864-1 · Cited by 97
Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson Disease
Pitts, T. E., Troche, M. S., Mann, G. D. C., Rosenbek, J. C., Okun, M. S., & Sapienza, C. M. (2010) · CHEST Journal · doi:10.1378/chest.10-0342 · Cited by 99
Evaluation of Epidemiologic and Animal Data Associating Pesticides With Parkinson???s Disease
Li, A. A., Mink, P. J., McIntosh, L. J., Teta, M. J., & Finley, B. L. (2005) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000174294.58575.3e · Cited by 99
Microstructure of the non‐rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of dopaminergic treatment
Brünner, H., Wetter, T. C., Högl, B., Yassouridis, A., Trenkwalder, C., & Frieß, E. (2002) · Movement Disorders · doi:10.1002/mds.10242 · Cited by 98
The effect of motion content in action naming by Parkinson’s disease patients
Herrera, E., Rodríguez‐Ferreiro, J., & Cuetos, F. (2010) · Cortex · doi:10.1016/j.cortex.2010.12.007 · Cited by 98
Quantitative EEG (QEEG) Measures Differentiate Parkinson's Disease (PD) Patients from Healthy Controls (HC)
Chaturvedi, M., Hatz, F., Gschwandtner, U., Bogaarts, J. G., Meyer, A., Fuhr, P., & Röth, V. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00003 · Cited by 98
Abnormalities of age-related T cell senescence in Parkinson’s disease
Williams‐Gray, C. H., Wijeyekoon, R., Scott, K. M., Hayat, S., Barker, R., & Jones, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1206-5 · Cited by 103
Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease
Cubo, E., Martín, P. M., Martin‐Gonzalez, J. A., Rodríguez‐Blázquez, C., Kulisevsky, J., & ELEP Group Members (2009) · Movement Disorders · doi:10.1002/mds.22896 · Cited by 98
Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson’s disease
Dörfler, P., Berg, D., Tucha, O. M., Benz, P. M., Meier-Meitinger, M., Alders, G. L., Lange, K. W., & Becker, G. (2003) · NeuroImage · doi:10.1016/s1053-8119(02)00035-6 · Cited by 98
Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis
Ahmed, S. S. S. J., & Santosh, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011252 · Cited by 103
Cortisol is higher in parkinsonism and associated with gait deficit
Charlett, A., Dobbs, R. J., Purkiss, A. G., Wrighe, D. J., Peterson, D. W., Weller, C., & Dobbs, S. M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00614.x · Cited by 98
SCOPA‐sleep and PDSS: Two scales for assessment of sleep disorder in Parkinson's disease
Martínez‐Martín, P., Jeukens‐Visser, M., Rodríguez‐Blázquez, C., Marinus, J., Chaudhuri, К. R., & van Hilten, J. J. (2008) · Movement Disorders · doi:10.1002/mds.22110 · Cited by 98
Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
Taschenberger, G., Garrido, M., Tereshchenko, Y., Bähr, M., Zweckstetter, M., & Kügler, S. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0926-8 · Cited by 100
Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET
Antonini, A., Kazumata, K., Feigin, A., Mandel, F. S., DHAWAN, V. M., Margouleff, C., & Eidelberg, D. (1998) · Movement Disorders · doi:10.1002/mds.870130212 · Cited by 98
Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.
Merello, M., Lees, A. J., Webster, R. A., Bovingdon, M., & Gordin, A. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.2.186 · Cited by 98
Self-citation
Progression of brain atrophy in the early stages of Parkinson's disease: A longitudinal tensor‐based morphometry study in de novo patients without cognitive impairment
Tessa, C., Lucetti, C., Giannelli, M., Diciotti, S., Poletti, M., Danti, S., Baldacci, F., Vignali, C., Bonuccelli, U., Mascalchi, M., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22449 · Cited by 97
Supervisory and routine processes in noun and verb generation in nondemented patients with Parkinson's disease.
Crescentini, C., Mondolo, F., Biasutti, E., & Shallice, T. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.08.021 · Cited by 99
Effects of augmented visual feedback during balance training in Parkinson's disease: A pilot randomized clinical trial
van den Heuvel, M. R. C., Kwakkel, G., Beek, P. J., Berendse, H. W., Daffertshofer, A., & van Wegen, E. E. H. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.09.022 · Cited by 97
Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson’s disease: a randomised blinded evaluation
Blomstedt, P. C., Persson, R. S., Hariz, G., Linder, J., Fredricks, A., Häggström, B., Philipsson, J., Forsgren, L., & Hariz, M. I. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317219 · Cited by 97
Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes
Strekalova, H., Buhmann, C., KLEENE, R. B., Eggers, C., Saffell, J. L., Hemperly, J. J., Weiller, C., Müller‐Thomsen, T., & Schachner, M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.11.013 · Cited by 98
Metabolomic analysis of urine and serum in Parkinson’s disease
Michell, A. W., Mosedale, D. E., Grainger, D. J., & Barker, R. A. (2008) · Metabolomics · doi:10.1007/s11306-008-0111-9 · Cited by 98
Independent validation of the scales for outcomes in Parkinson’s disease‐autonomic (SCOPA‐AUT)
Rodríguez‐Blázquez, C., Forjaz, M. J., Payo, B. F., de Pedro-Cuesta, J., Martínez‐Martín, P., & on behalf of the Longitudinal Parkinson’s Disease Patient Study (Estudio longitudinal de pacientes con enfermedad de Parkinson–ELEP ) Group (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02788.x · Cited by 97
Prevalence and clinical profile of restless legs syndrome in Parkinson's disease
Verbaan, D., van Rooden, S. M., van Hilten, J. J., & Rijsman, R. M. (2010) · Movement Disorders · doi:10.1002/mds.23241 · Cited by 96
Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases
Ruffmann, C., Calboli, F. C. F., Bravi, I., Gveric, D. O., Curry, L. K., de Smith, A. J., Pavlou, S., Buxton, J. L., Blakemore, A. I. F., Takousis, P., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12294 · Cited by 100
Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism
Camicioli, R. M., Gee, M., Bouchard, T. P., Fisher, N., Hanstock, C. C., Emery, D. J., & Martin, W. R. W. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.002 · Cited by 96
Apathy, but Not Depression, Reflects Inefficient Cognitive Strategies in Parkinson's Disease
Varanese, S., Perfetti, B., Ghilardi, M. F., & Rocco, A. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017846 · Cited by 95
Comparison of 3T and 7T Susceptibility-Weighted Angiography of the Substantia Nigra in Diagnosing Parkinson Disease
Cosottini, M., Frosini, D., Pesaresi, I., Donatelli, G., Cecchi, P. C., Costagli, M., Biagi, L., Ceravolo, R., Bonuccelli, U., & Tosetti, M. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4158 · Cited by 95
Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson’s disease
Drapier, S., Raoul, S., Drapier, D., Leray, E., Lallement, F., Rivier, I., Sauleau, P., Lajat, Y., Edan, G., & Vérin, M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0704-4 · Cited by 96
Apathy in untreated early‐stage Parkinson disease: Relationship with other non‐motor symptoms
Dujardin, K., Langlois, C., Plomhause, L., Carette, A., Delliaux, M., Duhamel, A., & Defebvre, L. (2014) · Movement Disorders · doi:10.1002/mds.26058 · Cited by 94
Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
Hong, J. Y., Oh, J. S., Lee, I., Sunwoo, M. K., Ham, J. H., Lee, J. E., Sohn, Y. H., Kim, J. S., & Lee, P. H. (2014) · Neurology · doi:10.1212/wnl.0000000000000385 · Cited by 96
Determinants of delayed diagnosis in Parkinson’s disease
Breen, D. P., Evans, J., Farrell, K., Brayne, C., & Barker, R. A. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6905-3 · Cited by 94
Occupational therapy for patients with Parkinson's disease
Dixon, L., Duncan, D. C., Johnson, P., Kirkby, L., O'Connell, H., Taylor, H. J., & Deane, K. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002813.pub2 · Cited by 93
Neurofibrillary tangle parkinsonian disorders?tau pathology andtau genetics
Morris, H. R., Lees, A. J., & Wood, N. W. (1999) · Movement Disorders · doi:10.1002/1531-8257(199909)14:5 · Cited by 44
Silent saliva aspiration in Parkinson's disease
Rodrigues, B., Nóbrega, A. C., Sampaio, M. C., Argolo, N., & Melo, A. D. S. (2010) · Movement Disorders · doi:10.1002/mds.23301 · Cited by 94
Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins
Cox, D., Carver, J. A., & Ecroyd, H. W. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.024 · Cited by 98
Biomarkers of cognitive decline in Parkinson's disease
Lin, C., & Wu, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.010 · Cited by 100
The SCOPA–Motor Scale for assessment of Parkinson's disease is a consistent and valid measure
Martínez‐Martín, P., Benito‐León, J., Burguera, J. A., Castro, A., Linazasoro, G., Martínez‐Castrillo, J. C., Valldeoriola, F., Vázquez, A., Vivancos, F., del Val, J., et al. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.09.014 · Cited by 94
Epidemiology of Parkinson's disease
Rajput, A. H., & Birdi, S. (1997) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(97)00029-1 · Cited by 94
α1-Antichymotrypsin and IL-1β are not increased in CSF or serum in Alzheimer's disease
Pirttilä, T., Mehta, P. D., Frey, H., & Wı́sniewski, H. M. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90026-4 · Cited by 94
Sleep Attacks and Antiparkinsonian Drugs: A Pilot Prospective Pharmacoepidemiologic Study
Montastruc, J., Brefel‐Courbon, C., Sénard, J., Bagheri, H., Ferreira, J. J., Rascol, O., & Lapeyre‐Mestre, M. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200105000-00013 · Cited by 94
Cognitive phenotypes in parkinson's disease differ in terms of brain‐network organization and connectivity
Lopes, R., Delmaire, C., Defebvre, L., Moonen, A. J. H., Duits, A., Hofman, P. A. M., Leentjens, A. F. G., & Dujardin, K. (2016) · Human Brain Mapping · doi:10.1002/hbm.23474 · Cited by 91
Risk factors for hallucinations in Parkinson's disease: Results from a large prospective cohort study
Zhu, K., van Hilten, J. J., Putter, H., & Marinus, J. (2013) · Movement Disorders · doi:10.1002/mds.25389 · Cited by 93
Exploring gene-environment interactions in Parkinson’s disease
McCulloch, C. C., Kay, D. M., Factor, S. A., Samii, A., Nutt, J. G., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Montimurro, J. S., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0466-z · Cited by 93
Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei
Perry, R. H., Irving, D., & Tomlinson, B. E. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90037-n · Cited by 93
Diffusion weighted imaging best discriminates PD from MSA‐P: A comparison with tilt table testing and heart MIBG scintigraphy
Köllensperger, M., Seppi, K., Liener, C., Boesch, S., Heute, D., Mair, K. J., Mueller, J., Sawires, M., Scherfler, C., Schocke, M. F. H., et al. (2007) · Movement Disorders · doi:10.1002/mds.21614 · Cited by 92
Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson’s disease with and without dementia assessed using 123I-FP-CIT SPECT
Colloby, S. J., Williams, E. D., Burn, D. J., Lloyd, J. J., McKeith, I. G., & O'Brien, J. T. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1830-z · Cited by 92
Impact of Fatigue in Parkinson’s Disease: The Fatigue Impact Scale for Daily Use (D-FIS)
Martínez‐Martín, P., Catalán, M. J., Benito‐León, J., Moreno, Á. O., Zamarbide, I., Cubo, E., van Blercon, N., Arillo, V. M. C., Pondal, M., Linazasoro, G., et al. (2006) · Quality of Life Research · doi:10.1007/s11136-005-4181-0 · Cited by 91
Epidemiology of Multiple System Atrophy: A Prevalence and Pilot Risk Factor Study in Aquitaine, France
Chrysostome, V., Tison, F., Yekhlef, F., Sourgen, C., Baldi, I., & Dartigues, J. (2004) · Neuroepidemiology · doi:10.1159/000078506 · Cited by 92
Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease
Happe, S., Baier, P. C., Helmschmied, K., Meller, J., Tatsch, K., & Paulus, W. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0483-6 · Cited by 92
Malnutrition and associated factors in Chinese patients with Parkinson's disease: Results from a pilot investigation
Wang, G., Wan, Y., Cheng, Q., Xiao, Q., Wang, Y., Zhang, J., Ma, J., Wang, X.-J., Zhou, H.-Y., & Chen, S.-D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.009 · Cited by 92
Urinary dysfunction in Parkinson's disease: A review
Blackett, H., Walker, R. W., & Wood, B. H. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.10.016 · Cited by 92
Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)
Clarke, C. E., Patel, S., Ives, N., Rick, C. E., Woolley, R., Wheatley, K., Walker, M. F., Zhu, S., Kandiyali, R., Yao, G., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20630 · Cited by 110
Use of radiomic features and support vector machine to distinguish Parkinson’s disease cases from normal controls
Wu, Y., Jiang, J., Chen, L., Lu, J., Ge, J., Liu, F., Yu, J., Lin, W., Zuo, C., & Wang, J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.26 · Cited by 91
Genetic and environmental risk factors in Parkinson’s disease
Veldman, B. A. J., Wijn, A. M., Knoers, N. V. A. M., Praamstra, P., & Horstink, M. W. I. M. (1998) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(98)00009-2 · Cited by 91
Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication
Buhmann, C., Arlt, S., Kontush, A., Möller-Bertram, T., Sperber, S., Oechsner, M., Stuerenburg, H. J., & Beisiegel†, U. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.003 · Cited by 91
Genetic variability at the PARK16 locus
Tucci, A., Nalls, M. A., Houlden, H., Revesz, T., Singleton, A. B., Wood, N. W., Hardy, J., & Paisán-Ruiz, C. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.125 · Cited by 81
Stereotactic Targeting of the Globus Pallidus Internus in Parkinson's Disease: Imaging versus Electrophysiological Mapping
Guridi, J., Gorospe, A., Ramos, E., Linazasoro, G., Rodríguez‐Oroz, M., & Obeso, J. A. (1999) · Neurosurgery · doi:10.1097/00006123-199908000-00017 · Cited by 91
Parkinson’s disease and pesticide exposure – a new assessment
Allen, M. T., & Levy, L. S. (2013) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.798719 · Cited by 90
Functional Brain Connectome and Its Relation to Hoehn and Yahr Stage in Parkinson Disease
Suo, X., Lei, D., Li, N., Cheng, L., Chen, F., Wang, M., Kemp, G. J., Peng, R., & Gong, Q. (2017) · Radiology · doi:10.1148/radiol.2017162929 · Cited by 90
Mortality and quality of death certification in a cohort of patients with Parkinson’s disease and matched controls in North Wales, UK at 18 years: a community-based cohort study
Hobson, P., & Meara, J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018969 · Cited by 89
Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease
Deane, K. H., Spieker, S., & Clarke, C. E. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004554.pub2 · Cited by 90
Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease
Djamshidian, A., Jha, A., O’Sullivan, S. S., Silveira‐Moriyama, L., Jacobson, C., Brown, P., Lees, A. J., & Averbeck, B. B. (2010) · Movement Disorders · doi:10.1002/mds.23247 · Cited by 90
Self-citation
Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias
Bibl, M., Mollenhauer, B., Lewczuk, P., Esselmann, H., Wolf, S., Trenkwalder, C., Otto, M., Stiens, G., Rüther, E., Kornhuber, J., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001967 · Cited by 93
Recessively Inherited Parkinsonism
Brüggemann, N., Hagenah, J. M., Reetz, K., Schmidt, A., Kasten, M., Buchmann, I., Eckerle, S., Bähre, M., Münchau, A. M., Djarmati, A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.281 · Cited by 90
Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing
Wüllner, U., Schmitz‐Hübsch, T., Antony, G., Fimmers, R., Spottke, A. E., Oertel, W. H., Deuschl, G., Klockgether, T., Eggert, K. M., & e.V., O. B. O. T. K. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01982.x · Cited by 90
“Paradoxical Kinesis” is not a Hallmark of Parkinson's disease but a general property of the motor system
Ballanger, B., Thobois, S., Baraduc, P., Turner, R. S., Broussolle, E., & Desmurget, M. (2006) · Movement Disorders · doi:10.1002/mds.20987 · Cited by 97
Study of Cerebello-Thalamocortical Pathway by Transcranial Magnetic Stimulation in Parkinson's Disease
Carrillo, F., Palomar, F. J., Conde, V., Diaz-Corrales, F. J. J., Porcacchia, P., Fernández‐del‐Olmo, M., Koch, G., & Mir, P. (2013) · Brain stimulation · doi:10.1016/j.brs.2012.12.004 · Cited by 90
PARK3 Influences Age at Onset in Parkinson Disease: A Genome Scan in the GenePD Study
DeStefano, A. L., Lew, M., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Guttman, M., Montgomery, E. B., Waters, C., Singer, C., Watts, R. L., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339814 · Cited by 90
Magnetic Resonance Imaging Evidence of Decreased Putamenal Iron Content in Idiopathic Parkinson's Disease
Ryvlin, P., Broussolle, E., Piollet, H., Viallet, F., Khalfallah, Y., & Chazot, G. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540300057013 · Cited by 90
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease
Santangelo, G., Vitale, C., Trojano, L., Verde, F., Grossi, D., & Barone, P. (2009) · Movement Disorders · doi:10.1002/mds.22472 · Cited by 89
Patterns of cortical thinning in idiopathic rapid eye movement sleep behavior disorder
Rahayel, S., Montplaisir, J. Y., Monchi, O., Bedetti, C., Postuma, R. B., Brambati, S. M., Carrier, J., Joubert, S., Latreille, V., Jubault, T., et al. (2014) · Movement Disorders · doi:10.1002/mds.25820 · Cited by 89
Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
Khan, A., Jahan, S., Imtiyaz, Z., Alshahrani, S., Makeen, H. A., Alshehri, B., Kumar, A., Arafah, A. M., & Rehman, M. U. (2020) · Biomedicines · doi:10.3390/biomedicines8080284 · Cited by 93
Within- and across-network alterations of the sensorimotor network in Parkinson’s disease
Caspers, J., Rubbert, C., Eickhoff, S. B., Hoffstaedter, F., Südmeyer, M., Hartmann, C. J., Sigl, B., Teichert, N., Aissa, J., Turowski, B., et al. (2021) · Neuroradiology · doi:10.1007/s00234-021-02731-w · Cited by 90
Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease
Kikuchi, A., Takeda, A., Kimpara, T., Nakagawa, M., Kawashima, R., Sugiura, M., Kinomura, S., Fukuda, H., Chida, K., Okita, N., et al. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00641-4 · Cited by 89
The Prevalence of Autonomic Symptoms in Dementia and Their Association with Physical Activity, Activities of Daily Living and Quality of Life
Allan, L. M., McKeith, I. G., Ballard, C. G., & Kenny, R. A. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000094971 · Cited by 90
Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions
van Zagten, M., Lodder, J., & Kessels, F. (1998) · Movement Disorders · doi:10.1002/mds.870130119 · Cited by 89
Levodopa responsiveness in disorders with parkinsonism: A review of the literature
Constantinescu, R., Richard, I. H., & Kurlan, R. (2007) · Movement Disorders · doi:10.1002/mds.21578 · Cited by 92
Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease
Depboylu, C., Schafer, M. K.-H., Arias-Carrión, Ó., Oertel, W. H., Weihe, E., & Höglinger, G. U. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31820805b9 · Cited by 91
Zolpidem in Parkinson's disease
Daniele, A., Albanese, A., Gainotti, G., Gregori, B., & Bartolomeo, P. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62416-6 · Cited by 89
New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies
Leigh, P. N., Probst, A., Dale, G. E., Power, D., Brion, J., Dodson, A. R., & Anderton, B. H. (1989) · Acta Neuropathologica · doi:10.1007/bf00308959 · Cited by 89
The Validity of the Hospital Anxiety and Depression Scale and the Geriatric Depression Scale in Parkinson’s Disease
Mondolo, F., Jahanshahi, M., Granà, A., Biasutti, E., Cacciatori, E., & Di Benedetto, P. (2006) · Behavioural Neurology · doi:10.1155/2006/136945 · Cited by 88
The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease
Rodríguez‐Blázquez, C., Rojo-Abuín, J. M., Álvarez, M., Arakaki, T., Bergareche‐Yarza, A., Chade, A. R., Garretto, N., Gershanik, O. S., Kurtis, M. M., Martínez‐Castrillo, J. C., et al. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.05.017 · Cited by 88
Redefining Bradykinesia
Bologna, M., Espay, A. J., Fasano, A. A., Paparella, G., Hallett, M., & Berardelli, A. (2023) · Movement Disorders · doi:10.1002/mds.29362 · Cited by 100
Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients?
Nóbrega, A. C., Rodrigues, B., & Melo, A. D. S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.12.007 · Cited by 88
Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease
Riley, D. E. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.56 · Cited by 88
Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis
Nemmi, F., Sabatini, U., Rascol, O., & Péran, P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.010 · Cited by 91
The black stuff and Konstantin Nikolaevich Tretiakoff
Lees, A. J., Selikhova, M. V., de Andrade, L. A. F., & Duyckaerts, C. J. (2008) · Movement Disorders · doi:10.1002/mds.21855 · Cited by 88
Self-citation
Anemia or low hemoglobin levels preceding Parkinson disease: A case-control study
Savica, R., Grossardt, B. R., Carlin, J. M., Icen, M., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., Steensma, D. P., & Rocca, W. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd80c1 · Cited by 87
Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community
Mahlknecht, P., Gasperi, A., Willeit, P., Kiechl, S. J., Stockner, H., Willeit, J., Rungger, G., Sawires, M., Nocker, M., Rastner, V., et al. (2016) · Movement Disorders · doi:10.1002/mds.26674 · Cited by 87
Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
Nicoletti, A. S. Q., Luca, A., Baschi, R., Cicero, C. E., Mostile, G., Davì, M., Pilati, L., Restivo, V., Zappia, M., & Monastero, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00021 · Cited by 88
Neuropathology of prodromal Lewy body disease
Iranzo, Á., Gelpí, E., Tolosa, E. S., Molinuevo, J. L., Serradell, M., Gaig, C., & Santamaría, J. (2014) · Movement Disorders · doi:10.1002/mds.25825 · Cited by 89
Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease
Macedo, M. G., Verbaan, D., Fang, Y., van Rooden, S. M., Jeukens‐Visser, M., Anar, B., Uras, A., Groen, J. L., Rizzu, P., van Hilten, J. J., et al. (2008) · Movement Disorders · doi:10.1002/mds.22287 · Cited by 87

Authors: Gibb, W. R., & Lees, A. J.
ORCID: Gibb, W R
Lees, A J
Venue: Journal of Neurology, Neurosurgery & Psychiatry
Publisher: BMJ
Published: 1988-06-01
Volume: 51
Issue: 6
Pages: 745-752
ISSN: 0022-3050 (ISSN-L)
DOI: 10.1136/jnnp.51.6.745
PMC: PMC1033142
OpenAlex: W2132881915
Semantic Scholar: 354cd1cf28ad23a8038bb3c576ff7791b3c74543
Cited by: 3,481
References: 39
Citations by year: 2026: 78 · 2025: 130 · 2024: 152 · 2023: 143 · 2022: 131 · 2021: 158 · 2020: 164 · 2019: 152 · 2018: 138 · 2017: 156 · 2016: 163 · 2015: 115 · 2014: 149 · 2013: 123 · 2012: 138
FWCI: 3.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
PubMed Central (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Lewy bodies, Parkinson's disease, pathogenesis, neurofilaments, substantia nigra, incidental Lewy body disease, age-related prevalence, neuronal loss
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Brain, Brain Damage, Chronic, Inclusion Bodies, Child, Humans, Middle Aged, Nerve Degeneration, Parkinson Disease, Substantia Nigra

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks